Medpace

Recent news

• Rating change
  Baird Downgrades Medpace(MEDP.US) to Hold Rating, Raises Target Price to $547
  Market Newswire · 2026/7/8
• Rating change
  RBC Capital Initiates Medpace(MEDP.US) With Buy Rating, Announces Target Price $522
  Market Newswire · 2026/3/3
• Rating change
  Mizuho Securities Maintains Medpace(MEDP.US) With Buy Rating, Maintains Target Price $665
  Market Newswire · 2026/7/29
• Rating change
  A Quick Look at Today's Ratings for Medpace(MEDP.US), With a Forecast Between $400 to $477
  Market Newswire · 2026/4/25
• Rating change
  Jefferies Maintains Medpace(MEDP.US) With Buy Rating, Raises Target Price to $560
  Market Newswire · 2026/2/13
• Medpace(MEDP.US) 10% Shareholder Sells US$15.36 Million in Common Stock
  Market Newswire · 2026/9/18
• Medpace(MEDP.US) 10% Shareholder Sells US$44.43 Million in Common Stock
  Market Newswire · 2026/9/24
• Rating change
  A Quick Look at Today's Ratings for Medpace(MEDP.US), With a Forecast Between $535 to $692
  Market Newswire · 2026/7/24
• Rating change
  Jefferies Maintains Medpace(MEDP.US) With Buy Rating, Maintains Target Price $560
  Market Newswire · 2026/2/13
• Rating change
  William Blair Maintains Medpace(MEDP.US) With Hold Rating
  Market Newswire · 2026/4/23
• Rating change
  Jefferies Maintains Medpace(MEDP.US) With Buy Rating, Cuts Target Price to $490
  Market Newswire · 2026/6/15
• UBS Initiates Medpace(MEDP.US) With Hold Rating, Announces Target Price $673
  Market Newswire · 2026/9/30
• Rating change
  Mizuho Securities Maintains Medpace(MEDP.US) With Buy Rating, Raises Target Price to $665
  Market Newswire · 2026/7/25
• Rating change
  Barclays Upgrades Medpace(MEDP.US) to Hold Rating, Cuts Target Price to $500
  Market Newswire · 2026/3/6
• Rating change
  Mizuho Securities Maintains Medpace(MEDP.US) With Buy Rating, Raises Target Price to $586
  Market Newswire · 2026/7/13
• Rating change
  William Blair Initiates Medpace(MEDP.US) With Hold Rating
  Market Newswire · 2026/7/23
• Truist Financial Maintains Medpace(MEDP.US) With Hold Rating
  Market Newswire · 2026/9/17
• Rating change
  RBC Capital Maintains Medpace(MEDP.US) With Buy Rating, Maintains Target Price $522
  Market Newswire · 2026/4/16
• Medpace(MEDP.US) 10% Shareholder Sells US$6.75 Million in Common Stock
  Market Newswire · 2026/9/22
• Rating change
  Truist Financial Maintains Medpace(MEDP.US) With Hold Rating, Maintains Target Price $609
  Market Newswire · 2026/7/29

Headlines are aggregated automatically and are not independently verified or edited by our team.